SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: Rande Is who wrote (21761)3/6/2000 6:34:00 PM
From: Steven Finkel  Respond to of 57584
 
Rande;

great day for lightpath. Just a quick question,any thoughts on coms or palm? They have both given back quite a bit recently and wondered whether they are ripe for investment.



To: Rande Is who wrote (21761)3/6/2000 8:51:00 PM
From: Paullie  Read Replies (1) | Respond to of 57584
 
Rande,

In regards to LU/LPTHA, I would like you to click on this message. As far as the validity, who knows.

Message 12654183

You may have seen this, but if not you surely will be excited.

I barely caught the conversation about LPTHA. When you said Warren, did you mean our home land, or another state?

Paullie



To: Rande Is who wrote (21761)3/6/2000 8:55:00 PM
From: DlphcOracl  Respond to of 57584
 
Rande Is, et al: ABSC (Aurora BioSciences), a top-tier small cap biotech stock with proprietary technology used by players involved in genomics research and pharmaceuticals, is down from $140 to $101 in last 3 trading sessions on low volume (profit-taking). Nice buying op here, IMO.